Percheron Therapeutics Limited Share Price Börse Stuttgart
Equities
AWY0
AU0000317281
Biotechnology & Medical Research
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.06 EUR | +30.43% | +10.31% | +33.72% |
01:44am | Percheron Therapeutics Names Chief Medical Advisor | MT |
05-29 | Percheron Therapeutics Completes Enrollment for Phase Two Muscular Dystrophy Trial; Shares Rise 3% | MT |
Sales 2024 * | 3.6M 2.4M 2.2M 188M | Sales 2025 * | 5.3M 3.53M 3.25M 276M | Capitalization | 80.24M 53.5M 49.13M 4.19B |
---|---|---|---|---|---|
Net income 2024 * | -17M -11.34M -10.41M -887M | Net income 2025 * | -31M -20.67M -18.98M -1.62B | EV / Sales 2024 * | 19.8 x |
Net cash position 2024 * | 8.92M 5.95M 5.46M 465M | Net cash position 2025 * | 17.43M 11.62M 10.67M 909M | EV / Sales 2025 * | 11.9 x |
P/E ratio 2024 * |
-5.68
x | P/E ratio 2025 * |
-2.26
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.66% |
1 week | +10.31% | ||
1 month | +15.58% | ||
3 months | -5.15% | ||
6 months | +37.72% | ||
Current year | +33.72% |
Managers | Title | Age | Since |
---|---|---|---|
James Garner
CEO | Chief Executive Officer | - | 07/05/23 |
Phillip Hains
DFI | Director of Finance/CFO | 64 | 08/11/06 |
Anthony Filippis
COO | Chief Operating Officer | - | 31/10/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Phillip Hains
DFI | Director of Finance/CFO | 64 | 08/11/06 |
Ben Price
BRD | Director/Board Member | 68 | 03/10/21 |
James Garner
CEO | Chief Executive Officer | - | 07/05/23 |
Date | Price | Change |
---|---|---|
03/06/24 | 0.0518 | +12.61% |
31/05/24 | 0.046 | +10.05% |
30/05/24 | 0.0418 | -4.13% |
29/05/24 | 0.0436 | +4.31% |
28/05/24 | 0.0418 | 0.00% |
Delayed Quote Börse Stuttgart, June 03, 2024 at 09:32 am
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+14.00% | 118B | |
+12.55% | 106B | |
-4.42% | 24.28B | |
+1.14% | 21.96B | |
-9.35% | 18.16B | |
-42.28% | 16.37B | |
-18.31% | 15.56B | |
+4.20% | 13.63B | |
+28.83% | 12.27B |
- Stock Market
- Equities
- PER Stock
- AWY0 Stock